Dapagliflozin in phenotypically stratified HFpEF without myocardial fibrosis: the STADIA-HFpEF randomized crossover trial.

Scheffer M, van Maarschalkerwaart W, Dong C, Landzaat JWD, Nedenyi F, Delalat S, Sultana I, Jarkas O, Röst G, Driessen-Waaijer A, Hamdani N, van Heerebeek L

Open source

DOI: 10.1093/ehjcvp/pvag091
Published: 2026 Oct 17
Container: European heart journal. Cardiovascular pharmacotherapy
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ehjcvp/pvag091,
  title = {Dapagliflozin in phenotypically stratified HFpEF without myocardial fibrosis: the STADIA-HFpEF randomized crossover trial.},
  author = {Scheffer M and van Maarschalkerwaart W and Dong C and Landzaat JWD and Nedenyi F and Delalat S and Sultana I and Jarkas O and Röst G and Driessen-Waaijer A and Hamdani N and van Heerebeek L},
  year = {2026},
  journal = {European heart journal. Cardiovascular pharmacotherapy},
  doi = {10.1093/ehjcvp/pvag091},
  url = {https://doi.org/10.1093/ehjcvp/pvag091}
}

RIS

TY  - JOUR
TI  - Dapagliflozin in phenotypically stratified HFpEF without myocardial fibrosis: the STADIA-HFpEF randomized crossover trial.
AU  - Scheffer M
AU  - van Maarschalkerwaart W
AU  - Dong C
AU  - Landzaat JWD
AU  - Nedenyi F
AU  - Delalat S
AU  - Sultana I
AU  - Jarkas O
AU  - Röst G
AU  - Driessen-Waaijer A
AU  - Hamdani N
AU  - van Heerebeek L
PY  - 2026
JO  - European heart journal. Cardiovascular pharmacotherapy
DO  - 10.1093/ehjcvp/pvag091
UR  - https://doi.org/10.1093/ehjcvp/pvag091
ER  -

APA

M, S., W, V. M., C, D., JWD, L., F, N., S, D., I, S., O, J., G, R., A, D., N, H., & L, V. H. (2026). Dapagliflozin in phenotypically stratified HFpEF without myocardial fibrosis: the STADIA-HFpEF randomized crossover trial.. European heart journal. Cardiovascular pharmacotherapy. https://doi.org/10.1093/ehjcvp/pvag091

Source records

pubmed · retrieved 2026-11-10T20:44:27.499Z